Baird Maintains Outperform on Twist Bioscience, Raises Price Target to $65
Benzinga Newsdesk 6 months ago
NewsPrice TargetAnalyst Ratings
Baird analyst Catherine Ramsey maintains Twist Bioscience (NASDAQ:TWST) with a Outperform and raises the price target from $50 to $65.
Baird analyst Catherine Ramsey maintains Twist Bioscience (NASDAQ:TWST) with a Outperform and raises the price target from $50 to $65.